Determining the Optimal Dose of AD-211 in Patients With Osteoarthritis of the Knee
ConditionOsteoarthritis of the Knees
Trial statusNot yet recruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age19-75
SponsorAddpharma Inc.
About this trial
The purpose of this study is to determine the optimal dose of AD-211 in patients with osteoarthritis of the knee.
Eligibility criteria
Qualifiers
Signed informed consent
Patients with osteoarthritis of the Knee
Other inclusions applied
Disqualifiers
Patients with secondary osteoarthritis of the knee
Other exclusions applied
Trial design
Treatments tested in this trial
- AD-211-L
- AD-211-M
- AD-211-H
- AD-2113
- Placebo to AD-211-L/M
- Placebo to AD-211-H
- Placebo to AD-2113
Treatment groups
200 Participants
are divided into 4 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov